Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways
K Koushki, SK Shahbaz, K Mashayekhi… - Clinical reviews in …, 2021 - Springer
Atherosclerosis is one type of cardiovascular disease (CVD) in which activation of the
NLRP3 inflammasome and toll-like receptor (TLR) pathways is implicated. One of the most …
NLRP3 inflammasome and toll-like receptor (TLR) pathways is implicated. One of the most …
Statins for the primary prevention of cardiovascular disease
F Taylor, K Ward, THM Moore, M Burke… - Cochrane database …, 2011 - cochranelibrary.com
Background Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD)
events in people with and without a past history of coronary heart disease (CHD) is an …
events in people with and without a past history of coronary heart disease (CHD) is an …
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration - The lancet, 2010 - thelancet.com
Background Uncertainties persist about the magnitude of associations of diabetes mellitus
and fasting glucose concentration with risk of coronary heart disease and major stroke …
and fasting glucose concentration with risk of coronary heart disease and major stroke …
Major lipids, apolipoproteins, and risk of vascular disease
R Assessment - Jama, 2009 - jamanetwork.com
Context Associations of major lipids and apolipoproteins with the risk of vascular disease
have not been reliably quantified. Objective To assess major lipids and apolipoproteins in …
have not been reliably quantified. Objective To assess major lipids and apolipoproteins in …
High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD) a randomized superiority trial
Background: Current guidelines call for high-intensity statin therapy in patients with
cardiovascular disease on the basis of several previous “more versus less statins” trials …
cardiovascular disease on the basis of several previous “more versus less statins” trials …
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
Heart Protection Study Collaborative Group - The Lancet, 2002 - Elsevier
BACKGROUND: Throughout the usual LDL cholesterol range in Western populations, lower
blood concentrations are associated with lower cardiovascular disease risk. In such …
blood concentrations are associated with lower cardiovascular disease risk. In such …
Cardiac fibroblasts: at the heart of myocardial remodeling
KE Porter, NA Turner - Pharmacology & therapeutics, 2009 - Elsevier
Cardiac fibroblasts are the most prevalent cell type in the heart and play a key role in
regulating normal myocardial function and in the adverse myocardial remodeling that occurs …
regulating normal myocardial function and in the adverse myocardial remodeling that occurs …
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
JM Esdaile, M Abrahamowicz, T Grodzicky… - Arthritis & …, 2001 - Wiley Online Library
Objective The frequency of coronary heart disease (CHD) and stroke are increased in
systemic lupus erythematosus (SLE), but the extent of the increase is uncertain. We sought …
systemic lupus erythematosus (SLE), but the extent of the increase is uncertain. We sought …
LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
U Ravnskov, M de Lorgeril, DM Diamond… - Expert review of …, 2018 - Taylor & Francis
Introduction: For half a century, a high level of total cholesterol (TC) or low-density
lipoprotein cholesterol (LDL-C) has been considered to be the major cause of …
lipoprotein cholesterol (LDL-C) has been considered to be the major cause of …
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi, Z Luo, I Shiojima, A Bialik, D Fulton… - Nature medicine, 2000 - nature.com
Recent studies suggest that statins can function to protect the vasculature in a manner that is
independent of their lipid-lowering activity. We show here that statins rapidly activate the …
independent of their lipid-lowering activity. We show here that statins rapidly activate the …